Barclays: EU Q1 earnings show strongest growth in years By Investing.com

Barclays says Q1 EPS growth is tracking at 27% in the US and 7% in Europe, with reported firms showing 16% growth in the US and 4% in Europe. Full-year 2026 EPS revisions have turned positive in the US, led by AI and technology, while Europe remains slightly negative and guidance is cautious due to war-related demand, supply chain, and input-cost pressures affecting about 75% of reported firms. Energy and semiconductors are seeing the biggest upgrades, but the article still points to mixed, regionally divergent earnings momentum rather than a broad market catalyst.

Analysis

The key market implication is not that earnings are simply strong, but that the dispersion between US and Europe is becoming self-reinforcing. Positive US revisions concentrated in AI/technology create a capex feedback loop: hyperscaler demand supports semis, semicap, power infrastructure, and software, while Europe’s weaker revision profile keeps multiple expansion capped even when headline prints beat. That means the next leg is likely a factor trade, not a broad beta trade: long US growth quality versus Europe cyclicals/consumer exposure, especially where guidance is already turning defensive.

The second-order effect in Europe is margin pressure migrating from demand to mix. If war-related disruptions are hitting roughly three-quarters of reporting firms, the real vulnerability is not just direct energy or logistics cost, but deferred orders and inventory caution in downstream industrials and discretionary names. That typically shows up with a lag of 1-2 quarters, so the current stability in global PMIs may be too early to trust for Europe-specific earnings recovery; revisions often bottom only after analysts fully reset estimates.

For Barclays, the near-term upside is modest but real if rates and loan-loss assumptions stay benign. Still, banks are not the cleanest expression of improving earnings breadth because they are exposed to the same European revision drag and to any renewed risk-off move from geopolitics. The better read-through is that cross-border capital allocation should continue favoring US domestically leveraged quality over Europe, reinforcing the valuation gap rather than closing it.

The contrarian risk is consensus may be underestimating how much of the US revision strength is front-loaded into a narrow set of AI beneficiaries. If enterprise spend stalls or capex cyclicality rolls over, the “broadening” narrative could fade fast, leaving the market overexposed to crowded winners. Conversely, if geopolitical shocks worsen, energy and defense outperformance could offset cyclicals faster than expected, but that would likely come with multiple compression elsewhere rather than a clean equity bid.

Key Decisions for Investors

• Long XLK / short VGK for a 1-3 month relative-value expression of the US revision premium; thesis is that US estimate upgrades remain concentrated and self-reinforcing while Europe stays capped by cautious guidance.
• Within US tech, favor semis over software: long SOXX on a 3-6 month horizon; the earnings revision cycle is still being pulled by AI capex rather than broad demand, giving the trade better near-term momentum and better operating leverage.
• Short European consumer/discretionary exposure via XLY-style proxies or selective single-name shorts over the next earnings cycle; guidance risk is more important than beats, and the lagged demand hit from geopolitics should surface over 1-2 quarters.
• For a more defensive pair, long U.S. banks with better domestic earnings momentum versus European banks using XLF / short EUFN; risk/reward is attractive if U.S. credit stays stable and European revisions keep drifting lower.
• Avoid chasing broad Europe beta until revisions turn positive for at least two consecutive months; if global PMIs improve but Europe-specific estimate cuts continue, the market is likely to punish cyclicals on every rally.